AstraZeneca will utilize the newly launched Proteome-SEQ™ service from Biognosys Proteome-SEQ™ standardized discovery service enables precise quantification of large proteomes across multiple samples November 21, 20 - Multiple discovery - Document - PDFSEARCH.IO

First Page	Meta Content
	AstraZeneca will utilize the newly launched Proteome-SEQ™ service from Biognosys Proteome-SEQ™ standardized discovery service enables precise quantification of large proteomes across multiple samples November 21, 20 Add to Reading List Document Date: 2014-11-24 04:00:53 Open Document File Size: 135,26 KB Share Result on Facebook City Zurich / / Company Biognosys AG / AstraZeneca / Proteomics Company / / IndustryTerm pharmaceutical / company offering services / reproducible and accurate quantification / mass spectrometric technology / / Technology mass spectrometric technology / proteomics technology / technology of Biognosys / / SocialTag Genomics Proteins Science Mass spectrometry Proteome Ruedi Aebersold Quantitative proteomics Gene expression Bioinformatics Biology

AstraZeneca will utilize the newly launched Proteome-SEQ™ service from Biognosys Proteome-SEQ™ standardized discovery service enables precise quantification of large proteomes across multiple samples November 21, 20Add to Reading List